Literature DB >> 22751602

Ustekinumab for psoriasis and psoriatic arthritis.

Ari Michael Goldminz1, Alice Bendix Gottlieb.   

Abstract

Ustekinumab, which is approved for the treatment of moderate to severe psoriasis, has been shown in phase II clinical trials to be efficacious in controlling the signs and symptoms of psoriatic arthritis. Ustekinumab appears to be well tolerated, but its longterm safety profile is not yet known.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22751602     DOI： 10.3899/jrheum.120253

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  10 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  The synovio-entheseal complex in enthesoarthritis.

Authors:  Angelo De Cata; Michele Inglese; Rosa Rubino; Francesca Molinaro; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2015-02-12       Impact factor: 3.984

Review 3.  Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis-A Review.

Authors:  Abigail Cline; Andrew Berg; Gregory J Bartos; Lindsay C Strowd; Steven R Feldman
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

Review 4.  Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications.

Authors:  Jie Wang; Yow-Ming C Wang; Hae-Young Ahn
Journal:  AAPS J       Date:  2014-07-04       Impact factor: 4.009

Review 5.  Ustekinumab: a review of its use in psoriatic arthritis.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

6.  Th17 Cells Contribute to the Pathology of Autoimmune Hypophysitis.

Authors:  Paulina Chalan; Nithya Thomas; Patrizio Caturegli
Journal:  J Immunol       Date:  2021-05-19       Impact factor: 5.426

Review 7.  Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis.

Authors:  Abigail Cline; Gregory J Bartos; Lindsay C Strowd; Steven R Feldman
Journal:  Children (Basel)       Date:  2019-09-11

Review 8.  Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.

Authors:  Paolo Custurone; Luca Di Bartolomeo; Natasha Irrera; Francesco Borgia; Domenica Altavilla; Alessandra Bitto; Giovanni Pallio; Francesco Squadrito; Mario Vaccaro
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

9.  Machine learning reveals distinct gene signature profiles in lesional and nonlesional regions of inflammatory skin diseases.

Authors:  Brittany A Martínez; Sneha Shrotri; Kathryn M Kingsmore; Prathyusha Bachali; Amrie C Grammer; Peter E Lipsky
Journal:  Sci Adv       Date:  2022-04-29       Impact factor: 14.957

Review 10.  New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.

Authors:  Andrew C Palfreeman; Kay E McNamee; Fiona E McCann
Journal:  Drug Des Devel Ther       Date:  2013-03-27       Impact factor: 4.162
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.